Recombinant FIV glycoprotein 160 and P24 gag protein
US6228608A · kind A · utility
13Cited by
12References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 1991 |
| Grant date | May 8, 2001 |
| Priority date | — |
| Expiry date | Feb 28, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Feline immunodeficiency virus antigens from gp160 envelope protein, gp120 envelope protein and p24 gag protein, useful for the diagnosis, treatment, and prevention of FIV. The invention may also be used to purify FIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.